Hims & Hers Health reported Q1 2025 revenue of $586.0M (+110.7% YoY), beat analyst consensus of $538.6M by $47.4M. Diluted EPS came in at $0.20 (+300.0% YoY), beat the $0.12 consensus by $0.08.
Trailing eight quarters through Q1 2025
Common questions about Hims & Hers Health's Q1 2025 earnings report.
Hims & Hers Health (HIMS) reported Q1 2025 earnings on May 5, 2025 after market close.
Hims & Hers Health reported revenue of $586.0M and diluted EPS of $0.20 for Q1 2025.
Revenue beat the consensus estimate of $538.6M by $47.4M. EPS beat the consensus estimate of $0.12 by $0.08.
Compared to the same quarter a year prior, revenue grew 110.7% from $278.2M a year earlier and diluted EPS grew 300.0% from $0.05.
You can read the 10-Q periodic report (0001773751-25-000154) directly on SEC EDGAR. The filing index links above go to sec.gov.